Nihon University Itabashi Hospital
Tokyo, Japan
University hospital in Itabashi, Tokyo
30-1 Oyaguchikamicho, Itabashi City, Tokyo 173-8610
About Nihon University Itabashi Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
8
Hoffmann-La Roche
5
Incyte Corporation
2
Janssen Research & Development, LLC
2
Japan Rhabdomyosarcoma Study Group
2
Amgen
1
Associations for Establishment of Evidence in Interventions
1
Boston Scientific Corporation
1
Bristol-Myers Squibb
1
Daiichi Sankyo Co., Ltd.
1
EMD Serono Research & Development Institute, Inc.
1
Clinical Trials at Nihon University Itabashi Hospital
During the past decade, Nihon University Itabashi Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 15 clinical trials were completed, i.e. on
average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease
2005-07-01
2012-08-01
Completed
6
Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
2004-05-01
Unknown status
41
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
2004-05-01
Unknown status
32
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
2012-11-01
2018-12-22
Completed
1,684
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,068
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
2014-07-22
2017-06-05
Completed
2,725
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Nihon University Itabashi Hospital" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Hoffmann-La Roche" with 5 trials
sponsored, "Incyte Corporation" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Japan Rhabdomyosarcoma Study Group"
with 2 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nihon University Itabashi Hospital"
#1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Chugai Pharmaceutical Co." with 1 trials as a collaborator and "Japan Clinical Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Nihon University Itabashi Hospital
According to Clinical.Site data, the most researched conditions in "Nihon University Itabashi Hospital" are
"Systemic Lupus Erythematosus" (3 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials) and "Sarcoma" (2 trials). Many other conditions were trialed in "Nihon University Itabashi Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Nihon University Itabashi Hospital
Most popular intervention types in "Nihon University Itabashi Hospital" are "Drug" (29 trials), "Biological" (5 trials), "Device" (4 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Aflibercept" (2 trials) and "Nipocalimab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Nihon University Itabashi Hospital
The vast majority of trials in "Nihon University Itabashi Hospital" are
37 trials for "All" genders.
Clinical Trials Status at Nihon University Itabashi Hospital
Currently, there are NaN active trials in "Nihon University Itabashi Hospital".
undefined are not yet recruiting,
9 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Nihon University Itabashi Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Nihon University Itabashi Hospital, 2 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".